Efficacy of a synthetic collagen-based sealant (TachoSil®) in preventing cerebrospinal fluid leak following planned and incidental durotomies in spine surgery: a retrospective cohort study

Cerebrospinal fluid (CSF) leakage is a significant complication following planned or incidental durotomies during spinal surgery. While primary suturing remains the gold standard for dural closure, it is common to necessitate adjunctive reinforcement techniques. This study aims to evaluate the efficacy of a synthetic collagen-based sealant patch (TachoSil<sup>®</sup>) in preventing CSF leaks in a large cohort of patients undergoing spinal surgery. A retrospective analysis was conducted in whom TachoSil<sup>®</sup> was used as a dural sealant, either following planned (n = 12) or incidental (n = 42) durotomies, or prophylactically (n = 31) after decompression for critical lumbar canal stenosis. The primary endpoint was the prevention and resolution rate of CSF leaks. Secondary endpoints included reoperation rates and postoperative complications. A total of 85 patients (6.8%) met the inclusion criteria (mean age, 64.7 ± 15.4 years). TachoSil® was used as monotherapy in 39 patients and in combination with primary suturing or other sealants in 46 patients. Overall, 66 patients (77.6%) did not require surgical reintervention. TachoSil® monotherapy was associated with a significantly higher success rate (89.7%) compared to combined techniques (68.2% for TachoSil® plus suturing and 60.0% for TachoSil® plus other sealants; p = 0.041). Excluding its prophylactic use (either planned or incidental durotomy, n = 54), its efficacy in avoiding reintervention was 86.7% for TachoSil® alone, 77.3% for TachoSil® plus suture, and 64.7% for TachoSil® plus other combinations of sealants (p = 0.67). Postoperative complications occurred in 22 patients (25.9%), primarily including persistent CSF fistula, pseudomeningocele formation, and surgical site infections. TachoSil® demonstrated high efficacy as a standalone dural reinforcement method and when combined with suture or other sealant techniques in preventing CSF leaks following spinal surgeries involving dural compromise.

Authors

Institutions

Publication Details

Journal
Neurosurgical Review
Published
2025-11-15
DOI
https://doi.org/10.1007/s10143-025-03917-z
Citations
1
Primary Topic
Head and Neck Surgical Oncology
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of a synthetic collagen-based sealant (TachoSil®) in preventing cerebrospinal fluid leak following planned and incidental durotomies in spine surgery: a retrospective cohort study

Javier Martín-Alonso, Antonio Montalvo-Afonso, Pedro David Delgado‐López, Vicente Martín-Velasco et al.
1 citations
Neurosurgical Review
Head and Neck Surgical Oncology
2.01
article

Efficacy of a synthetic collagen-based sealant (TachoSil®) in preventing cerebrospinal fluid leak following planned and incidental durotomies in spine surgery: a retrospective cohort study

Javier Martín-Alonso, Antonio Montalvo-Afonso, Pedro David Delgado‐López, Vicente Martín-Velasco, Rubén Diana Martín, Antonia Gutiérrez, Ane Barreras-García
article en
1 citations

Abstract

Cerebrospinal fluid (CSF) leakage is a significant complication following planned or incidental durotomies during spinal surgery. While primary suturing remains the gold standard for dural closure, it is common to necessitate adjunctive reinforcement techniques. This study aims to evaluate the efficacy of a synthetic collagen-based sealant patch (TachoSil<sup>®</sup>) in preventing CSF leaks in a large cohort of patients undergoing spinal surgery. A retrospective analysis was conducted in whom TachoSil<sup>®</sup> was used as a dural sealant, either following planned (n = 12) or incidental (n = 42) durotomies, or prophylactically (n = 31) after decompression for critical lumbar canal stenosis. The primary endpoint was the prevention and resolution rate of CSF leaks. Secondary endpoints included reoperation rates and postoperative complications. A total of 85 patients (6.8%) met the inclusion criteria (mean age, 64.7 ± 15.4 years). TachoSil® was used as monotherapy in 39 patients and in combination with primary suturing or other sealants in 46 patients. Overall, 66 patients (77.6%) did not require surgical reintervention. TachoSil® monotherapy was associated with a significantly higher success rate (89.7%) compared to combined techniques (68.2% for TachoSil® plus suturing and 60.0% for TachoSil® plus other sealants; p = 0.041). Excluding its prophylactic use (either planned or incidental durotomy, n = 54), its efficacy in avoiding reintervention was 86.7% for TachoSil® alone, 77.3% for TachoSil® plus suture, and 64.7% for TachoSil® plus other combinations of sealants (p = 0.67). Postoperative complications occurred in 22 patients (25.9%), primarily including persistent CSF fistula, pseudomeningocele formation, and surgical site infections. TachoSil® demonstrated high efficacy as a standalone dural reinforcement method and when combined with suture or other sealant techniques in preventing CSF leaks following spinal surgeries involving dural compromise.

Neurosurgical ReviewVol. 49(1)
Hospital Universitario de Burgos (ES)
Openalex Percentile: Top 10%
Head and Neck Surgical Oncology
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.